The impact of complete clearance and almost complete clearance of psoriasis on quality of life: a literature review

被引:9
作者
Boswell, Nicole D. [1 ]
Cook, Madison K. [1 ]
Balogh, Esther A. [1 ]
Feldman, Steven R. [1 ,2 ,3 ,4 ]
机构
[1] Wake Forest Sch Med, Ctr Dermatol Res, Dept Dermatol, Winston Salem, NC 27157 USA
[2] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC 27101 USA
[3] Wake Forest Sch Med, Dept Social Sci & Hlth Policy, Winston Salem, NC 27101 USA
[4] Univ Southern Denmark, Dept Dermatol, Odense, Denmark
关键词
Psoriasis; Quality of life; Biologics; Clearance of psoriasis; COMPLETE SKIN CLEARANCE; SYMPTOM SEVERITY; IMPROVEMENTS; MODERATE;
D O I
10.1007/s00403-022-02420-5
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Psoriasis is a chronic skin condition with systemic manifestations that have a detrimental impact on a patient's quality of life, affecting social, psychological, and sexual aspects of life. Complete clearance of lesions is a meaningful end goal of treatment; however, it is often difficult for patients to achieve. In this literature review, we summarized past studies that compared patients who achieved complete clearance to those who were almost clear to highlight the effect of complete clearance on psychological distress, social stigma, self-esteem, and interpersonal relationships in adult patients with psoriasis. Methods A literature search was performed through the PubMed database using the keywords "clearance of psoriasis", "complete clearance of psoriasis", "psychological impact psoriasis", "social impact psoriasis", and "stigma of psoriasis". Age (< 18) and language (only articles written in English were included) were the only exclusion criteria to include adult patients only. The information was then collected and evaluated to compare complete clearance and almost complete clearance of psoriasis. Results Of the patients with complete skin clearance (sPGA of 0), 61.4-91.1% reported a Dermatology Life Quality Index (DLQI) of 0, indicating no detectable impact of psoriasis on quality of life, compared to 45.7-48.3% who were almost clear. Patients who were completely clear felt psoriasis had less of an effect on their leisure activities and daily living compared to patients who were almost clear. Patient perceptions of disease severity also differed between the two groups, with the majority (65.5%) of those achieving complete clearance reporting a Psoriasis Symptom Inventory (PSI) of 0, which is consistent with their disease being "not at all severe", compared to 32.6% of those who were almost but not completely clear. While patients with complete clearance achieve a DLQI of 0 at a higher rate than those who have only almost complete clearance, the difference in the mean DLQI between patients with sPGA of 0 (completely clear) and sPGA of 1 (almost clear) is less than the minimal clinically important difference (MCID of 3-5) of the DLQI.
引用
收藏
页码:699 / 706
页数:8
相关论文
共 25 条
  • [1] Impact of psoriasis on quality of life in Iran
    Aghaei, Shahin
    Moradi, Ahmad
    Ardekani, Gholamreza Safaee
    [J]. INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2009, 75 (02) : 220
  • [2] Clearance is not a realistic expectation of psoriasis treatment
    Al-Suwaidan, SN
    Feldman, SR
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (05) : 796 - 802
  • [3] Patient perceptions of clear/almost clear skin in moderate-to-severe plaque psoriasis: results of the Clear About Psoriasis worldwide survey
    Armstrong, A.
    Jarvis, S.
    Boehncke, W. -H.
    Rajagopalan, M.
    Fernandez-Penas, P.
    Romiti, R.
    Bewley, A.
    Vaid, B.
    Huneault, L.
    Fox, T.
    Sodha, M.
    Warren, R. B.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (12) : 2200 - 2207
  • [4] Determining the Minimal Clinically Important Difference and Responsiveness of the Dermatogy Life Quality Index (DLQI): Further Data
    Basra, M. K. A.
    Salek, M. S.
    Camilleri, L.
    Sturkey, R.
    Finlay, A. Y.
    [J]. DERMATOLOGY, 2015, 230 (01) : 27 - 33
  • [5] Importance of Complete Skin Clearance in Psoriasis as a Treatment Goal: Implications for Patient-Reported Outcomes
    Blauvelt, Andrew
    Wu, Jashin J.
    Armstrong, April
    Menter, Alan
    Liu, Clive
    Jacobson, Abby
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2020, 19 (05) : 487 - 492
  • [6] Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life
    Boehm, D.
    Gissendanner, S. Stock
    Bangemann, K.
    Snitjer, I.
    Werfel, T.
    Weyergraf, A.
    Schulz, W.
    Jaeger, B.
    Schmid-Ott, G.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (02) : 220 - 226
  • [7] Factors associated with patient-reported importance of skin clearance among adults with psoriasis and atopic dermatitis
    Egeberg, Alexander
    Thyssen, Jacob P.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : 943 - 949
  • [8] Psoriasis patients with psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75-89 response: results from two phase 3 studies of secukinumab
    Elewski, Boni E.
    Puig, Lluis
    Mordin, Margaret
    Gilloteau, Isabelle
    Sherif, Bintu
    Fox, Todd
    Gnanasakthy, Ari
    Papavassilis, Charis
    Strober, Bruce E.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2017, 28 (06) : 492 - 499
  • [9] What is clearance worth? Patients' stated risk tolerance for psoriasis treatments
    Fairchild, Angelyn O.
    Reed, Shelby D.
    Johnson, F. Reed
    Anglin, Greg
    Wolka, Anne M.
    Noel, Rebecca A.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2017, 28 (08) : 709 - 715
  • [10] Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice
    Feldman, Steven R.
    Bushnell, Donald M.
    Klekotka, Paul A.
    Scanlon, Michael
    Martin, Mona L.
    Wade, Sally W.
    Yang, Wenjing
    Pinto, Lionel
    Kircik, Leon
    Viswanathan, Hema N.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (03) : 224 - 227